惠泰医疗
(688617)
| 流通市值：355.52亿 | | | 总市值：355.52亿 |
| 流通股本：9739.38万 | | | 总股本：9739.38万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 599,613,654.94 | 821,996,934.81 | 654,177,314.01 | 1,276,391,305.21 |
| 应收票据及应收账款 | 58,582,855.2 | 53,955,885.34 | 42,638,141.24 | 41,777,915.87 |
| 其中：应收票据 | 151,940 | 151,940 | 219,391.6 | 362,131.9 |
| 应收账款 | 58,430,915.2 | 53,803,945.34 | 42,418,749.64 | 41,415,783.97 |
| 预付款项 | 30,525,101.42 | 38,231,868.86 | 37,690,749.98 | 38,134,839.35 |
| 其他应收款合计 | 5,828,404.8 | 4,805,535.68 | 4,688,473.5 | 4,459,882.1 |
| 其中:应收利息 | - | - | 416,645.13 | - |
| 存货 | 409,258,823.79 | 362,815,660.89 | 349,660,493.93 | 327,953,140.74 |
| 其他流动资产 | 4,721,289.1 | 2,518,260.99 | 2,167,880.48 | 7,349,900.98 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,469,496,563.41 | 1,472,991,940.29 | 1,666,720,650.96 | 1,756,066,984.25 |
| 非流动资产: | | | | |
| 长期股权投资 | 45,514,201.7 | 42,953,438.54 | 40,947,765.72 | 38,655,456.4 |
| 其他权益工具投资 | 133,892,331.87 | 133,892,331.87 | 121,147,733.44 | 121,147,733.44 |
| 固定资产 | 534,148,168.4 | 437,174,273.69 | 418,154,509.3 | 399,366,483.38 |
| 在建工程 | 34,394,540.91 | 84,641,162.44 | 63,270,803.5 | 47,844,356.76 |
| 使用权资产 | 10,872,678.97 | 12,288,983.78 | 14,773,624.88 | 17,253,111.91 |
| 无形资产 | 400,350,957.47 | 80,168,562.67 | 81,439,767.7 | 83,004,883.09 |
| 商誉 | 48,133,117.11 | 48,133,117.11 | 48,133,117.11 | 48,133,117.11 |
| 长期待摊费用 | 3,746,414.4 | 4,390,791.07 | 5,230,904.77 | 5,951,799.1 |
| 递延所得税资产 | 12,758,709.06 | 12,793,273.58 | 9,564,389.08 | 10,732,163.28 |
| 其他非流动资产 | 110,613,488.02 | 412,767,793.69 | 138,701,262.65 | 44,826,206.72 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,334,424,607.91 | 1,269,203,728.44 | 941,363,878.15 | 816,915,311.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,803,921,171.32 | 2,742,195,668.73 | 2,608,084,529.11 | 2,572,982,295.44 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 70,000,000 |
| 应付票据及应付账款 | 55,850,135.18 | 55,383,320.24 | 68,119,457.9 | 42,726,085.19 |
| 应付账款 | 55,850,135.18 | 55,383,320.24 | 68,119,457.9 | 42,726,085.19 |
| 合同负债 | 28,269,665.78 | 42,633,142.24 | 43,896,909.86 | 44,395,898.73 |
| 应付职工薪酬 | 121,999,442.38 | 93,620,822.9 | 60,250,759.34 | 124,700,480.37 |
| 应交税费 | 38,024,165.29 | 39,687,711.14 | 26,296,230.45 | 24,362,333.17 |
| 其他应付款合计 | 92,924,914.24 | 296,341,879.38 | 274,398,089.59 | 265,863,882.66 |
| 应付股利 | - | 133,099,098 | - | - |
| 一年内到期的非流动负债 | 8,438,758.38 | 9,714,230.64 | 10,510,819.33 | 11,279,474.09 |
| 其他流动负债 | 2,110,027.66 | 3,998,008.6 | 2,965,740.83 | 4,841,674.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 347,617,108.91 | 541,379,115.14 | 486,438,007.3 | 588,169,828.92 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 295,500 | 591,000 |
| 租赁负债 | 4,004,164.66 | 4,504,813.86 | 6,254,861.38 | 7,988,002.78 |
| 递延收益 | 8,889,270.69 | 7,794,108.14 | 8,284,213.99 | 8,744,929.6 |
| 递延所得税负债 | 7,296,727.5 | 7,124,626.59 | 3,622,562.61 | 5,487,670.79 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 20,190,162.85 | 19,423,548.59 | 18,457,137.98 | 22,811,603.17 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 367,807,271.76 | 560,802,663.73 | 504,895,145.28 | 610,981,432.09 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 97,328,715 | 66,861,357 | 66,861,357 | 66,861,357 |
| 资本公积 | 768,819,890.82 | 727,861,068.58 | 727,386,458.09 | 724,040,835.54 |
| 减:库存股 | 59,990,496.75 | 59,990,496.75 | 59,990,496.75 | 59,990,496.75 |
| 其他综合收益 | 46,396,926.89 | 46,388,297.58 | 34,924,707.84 | 34,962,596.62 |
| 盈余公积 | 33,430,678.5 | 33,430,678.5 | 33,430,678.5 | 33,430,678.5 |
| 未分配利润 | 1,502,167,650.54 | 1,317,298,880.64 | 1,247,981,165.52 | 1,107,837,337.76 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,388,153,365 | 2,131,849,785.55 | 2,050,593,870.2 | 1,907,142,308.67 |
| 少数股东权益 | 47,960,534.56 | 49,543,219.45 | 52,595,513.63 | 54,858,554.68 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,436,113,899.56 | 2,181,393,005 | 2,103,189,383.83 | 1,962,000,863.35 |
| 负债和股东权益合计 | 2,803,921,171.32 | 2,742,195,668.73 | 2,608,084,529.11 | 2,572,982,295.44 |
| 公告日期 | 2024-10-26 | 2024-08-23 | 2024-04-26 | 2024-03-25 |
| 审计意见(境内) | | | | 标准无保留意见 |